For example, in 2017, Burkard et al. [20] used CRISPR/Cas9 technology to knock out CD163, a cell receptor involved in the invasion of porcine reproductive and respiratory syndrome virus, and successfully obtained gene-edited pigs capable of resisting the infection of reproductive and respiratory syndrome virus. This evidence concerns the gene CD163 and infection.